Article
A five‐gene signature may predict sunitinib sensitivity and serve as prognostic biomarkers for renal cell carcinoma
12 Jan 2018
Abstract excerpt
Sunitinib resistance is, nowadays, the major challenge for advanced renal cell carcinoma patients. Illuminating the potential mechanisms and exploring effective strategies to overcome sunitinib resistance are highly desired. We constructed a reliable gene signature which may function as biomarkers for prediction of sunitinib sensitivity and clinical prognosis. The gene expression profiles were obtained from The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
